Q3 2023 EPS Estimates for Integer Holdings Co. (NYSE:ITGR) Raised by Zacks Research

Integer Holdings Co. (NYSE:ITGR) – Zacks Research upped their Q3 2023 earnings estimates for Integer in a research report issued on Monday, September 11th. Zacks Research analyst D. Dey now forecasts that the medical equipment provider will post earnings of $1.04 per share for the quarter, up from their prior forecast of $1.03. The consensus estimate for Integer’s current full-year earnings is $4.33 per share. Zacks Research also issued estimates for Integer’s FY2023 earnings at $4.29 EPS, Q1 2024 earnings at $1.13 EPS, Q3 2024 earnings at $1.31 EPS, FY2024 earnings at $4.98 EPS, Q1 2025 earnings at $1.26 EPS and FY2025 earnings at $5.72 EPS.

A number of other analysts have also recently weighed in on the stock. StockNews.com assumed coverage on shares of Integer in a research note on Thursday, August 17th. They issued a “hold” rating for the company. KeyCorp boosted their price objective on shares of Integer from $96.00 to $105.00 and gave the stock an “overweight” rating in a research note on Friday, July 28th. TheStreet upgraded shares of Integer from a “c+” rating to a “b” rating in a research note on Thursday, July 27th. Benchmark boosted their price objective on shares of Integer from $90.00 to $105.00 and gave the stock a “buy” rating in a research note on Friday, July 28th. Finally, Wells Fargo & Company boosted their price objective on shares of Integer from $87.00 to $94.00 and gave the stock an “equal weight” rating in a research note on Friday, July 28th. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Integer has a consensus rating of “Hold” and an average target price of $93.83.

Integer Price Performance

NYSE ITGR opened at $81.22 on Wednesday. The company has a quick ratio of 1.94, a current ratio of 3.08 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $2.71 billion, a PE ratio of 38.31, a price-to-earnings-growth ratio of 1.53 and a beta of 1.11. The company has a 50 day moving average price of $85.77 and a two-hundred day moving average price of $82.18. Integer has a 12-month low of $50.05 and a 12-month high of $96.17.

Integer (NYSE:ITGR) last posted its earnings results on Thursday, July 27th. The medical equipment provider reported $1.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.99 by $0.15. The firm had revenue of $400.04 million during the quarter, compared to analysts’ expectations of $367.05 million. Integer had a net margin of 4.77% and a return on equity of 9.67%.

Institutional Investors Weigh In On Integer

Several institutional investors and hedge funds have recently bought and sold shares of ITGR. Earnest Partners LLC bought a new stake in Integer in the 4th quarter valued at $82,214,000. Silvercrest Asset Management Group LLC grew its holdings in shares of Integer by 40.9% in the 4th quarter. Silvercrest Asset Management Group LLC now owns 1,004,347 shares of the medical equipment provider’s stock worth $68,758,000 after purchasing an additional 291,616 shares during the last quarter. Norges Bank bought a new stake in shares of Integer in the 4th quarter worth about $19,491,000. Victory Capital Management Inc. grew its holdings in shares of Integer by 23.2% in the 1st quarter. Victory Capital Management Inc. now owns 1,422,398 shares of the medical equipment provider’s stock worth $110,236,000 after purchasing an additional 267,565 shares during the last quarter. Finally, Barclays PLC grew its holdings in shares of Integer by 1,422.2% in the 1st quarter. Barclays PLC now owns 269,059 shares of the medical equipment provider’s stock worth $20,853,000 after purchasing an additional 251,383 shares during the last quarter. Institutional investors own 99.29% of the company’s stock.

Insider Buying and Selling

In related news, Director Donald J. Spence sold 6,500 shares of the business’s stock in a transaction on Monday, September 11th. The shares were sold at an average price of $82.32, for a total transaction of $535,080.00. Following the transaction, the director now owns 18,781 shares of the company’s stock, valued at $1,546,051.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.84% of the stock is currently owned by insiders.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures.